GlaxoSmithKline (GSK) stock forecast for 2024

The forecast has been updated: June 22, 2022 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

49.15

Dividend Date

01.07.2022

Ex Dividend Date

19.05.2022

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $49.15 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the support level (42.7 $).

50 Day Moving Average is the resistance level (44.31 $).




GSK Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 41.74 41.04 42.52 3.48 %
Feb 42.13 41.23 43.28 4.75 %
Mar 42.28 41.14 42.63 3.48 %
Apr 42.12 41.62 43.38 4.05 %
May 41.53 40.78 42.64 4.37 %
Jun 43.05 42.46 43.62 2.66 %
Jul 44.69 43.87 45.34 3.23 %
Aug 44.74 43.72 45.44 3.80 %
Sep 45.97 45.34 47.17 3.88 %
Oct 46.31 45.24 47.34 4.43 %
Nov 45.57 44.68 46.74 4.41 %
Dec 44.64 44.17 45.48 2.87 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization

104 909 169 000 $

EBITDA

10 817 000 000

PE Ratio

16.74

PEG Ratio

1.822

Dividend Per Share

0.75

Dividend Yield

0.0482

EPS

2.466

Quarterly Earnings Growth YOY

0.671

Quarterly Revenue Growth YOY

0.318

Trailing PE

16.74

Forward PE

14.01

EV To Revenue

3.514

EV To EBITDA

12.78

52 Week High

46.59

52 Week Low

36.51

50 Day Moving Average

44.31

200 Day Moving Average

42.7

Shares Outstanding

2542020000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 41.74. Negative monthly dynamics of the instrument is expected with 3.484% volatility is expected.

Pessimistic forecast: 41.04

Optimistic: 42.52


GlaxoSmithKline stock forecast for Feb 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 42.13. Positive monthly dynamics of the instrument is expected with 4.745% volatility is expected.

Pessimistic forecast: 41.23

Optimistic: 43.28


GlaxoSmithKline stock forecast for Mar 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 42.28. Positive monthly dynamics of the instrument is expected with 3.482% volatility is expected.

Pessimistic forecast: 41.14

Optimistic: 42.63


GlaxoSmithKline stock forecast for Apr 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 42.12. Negative monthly dynamics of the instrument is expected with 4.051% volatility is expected.

Pessimistic forecast: 41.62

Optimistic: 43.38


GlaxoSmithKline stock forecast for May 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 41.53. Negative monthly dynamics of the instrument is expected with 4.367% volatility is expected.

Pessimistic forecast: 40.78

Optimistic: 42.64


GlaxoSmithKline stock forecast for Jun 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 43.05. Positive monthly dynamics of the instrument is expected with 2.656% volatility is expected.

Pessimistic forecast: 42.46

Optimistic: 43.62


GlaxoSmithKline stock forecast for Jul 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 44.69. Positive monthly dynamics of the instrument is expected with 3.230% volatility is expected.

Pessimistic forecast: 43.87

Optimistic: 45.34


GlaxoSmithKline stock forecast for Aug 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 44.74. Positive monthly dynamics of the instrument is expected with 3.802% volatility is expected.

Pessimistic forecast: 43.72

Optimistic: 45.44


GlaxoSmithKline stock forecast for Sep 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 45.97. Positive monthly dynamics of the instrument is expected with 3.877% volatility is expected.

Pessimistic forecast: 45.34

Optimistic: 47.17


GlaxoSmithKline stock forecast for Oct 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 46.31. Positive monthly dynamics of the instrument is expected with 4.426% volatility is expected.

Pessimistic forecast: 45.24

Optimistic: 47.34


GlaxoSmithKline stock forecast for Nov 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 45.57. Negative monthly dynamics of the instrument is expected with 4.410% volatility is expected.

Pessimistic forecast: 44.68

Optimistic: 46.74


GlaxoSmithKline stock forecast for Dec 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 44.64. Negative monthly dynamics of the instrument is expected with 2.871% volatility is expected.

Pessimistic forecast: 44.17

Optimistic: 45.48



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 109.45 (24.06.2022) 3.05 %
AbbVie Inc.
ABBV 152.34 (24.06.2022) 1.93 %
Aeterna Zentaris Inc.
AEZS 0.1887 (24.06.2022) -1.67 %
Allakos Inc.
ALLK 3.43 (24.06.2022) -1.72 %
Allogene Therapeutics, Inc.
ALLO 12.28 (24.06.2022) 0.74 %
Amgen Inc.
AMGN 245.37 (24.06.2022) 0.94 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 7.31 (24.06.2022) -0.54 %
Aurora Cannabis Inc.
ACB 1.53 (24.06.2022) 7.75 %
Becton Dickinson and Company
BDX 250.92 (24.06.2022) 3.46 %
Biogen Inc.
BIIB 211.93 (24.06.2022) 0.26 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 143.79 (24.06.2022) -0.28 %
BioNTech SE
BNTX 134.04 (24.06.2022) 1.32 %
bluebird bio, Inc.
BLUE 4.4 (24.06.2022) 2.80 %
Boston Scientific Corp.
BSX 38.02 (24.06.2022) 2.92 %
Bristol-Myers Squibb Company
BMY 78.96 (24.06.2022) 1.63 %
Canopy Growth Corp.
CGC 3.77 (24.06.2022) 4.72 %
Castle Biosciences, Inc.
CSTL 23.83 (24.06.2022) 7.78 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 32.76 (24.06.2022) 1.30 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 5.54 (24.06.2022) 4.53 %
Gilead Sciences, Inc.
GILD 63.08 (24.06.2022) 0.80 %
GlaxoSmithKline plc
GSK 43.69 (24.06.2022) 2.20 %
GoodRx Holdings, Inc.
GDRX 6.96 (24.06.2022) 3.73 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 78.19 (24.06.2022) 4.56 %
Inovio Pharmaceuticals, Inc.
INO 1.94 (24.06.2022) -3.48 %
Johnson & Johnson
JNJ 182.29 (24.06.2022) 1.46 %
Medtronic plc.
MDT 90.22 (24.06.2022) 1.75 %
Merck & Co., Inc.
MRK 93.13 (24.06.2022) 1.23 %
Moderna, Inc.
MRNA 144.27 (24.06.2022) 0.71 %
Novartis AG
NVS 84.83 (24.06.2022) 3.63 %
Novavax, Inc.
NVAX 51.67 (24.06.2022) -0.27 %
ObsEva SA
OBSV 1.89 (24.06.2022) -0.53 %
OrganiGram Holdings Inc.
OGI 1.06 (24.06.2022) 7.52 %
Pfizer Inc.
PFE 51.59 (24.06.2022) 2.99 %
Regeneron Pharmaceuticals, Inc.
REGN 612.49 (24.06.2022) 0.84 %
Sanofi
SNY 53.42 (24.06.2022) 5.95 %
Schrodinger, Inc.
SDGR 30.41 (24.06.2022) 3.26 %
Senseonics Holdings, Inc.
SENS 1.01 (24.06.2022) -1.94 %
Sorrento Therapeutics, Inc.
SRNE 2.07 (24.06.2022) -9.21 %
Stryker Corp.
SYK 204.43 (24.06.2022) 2.18 %
Sundial Growers Inc.
SNDL 0.39 (24.06.2022) 5.41 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.74 (24.06.2022) 0.91 %
Thermo Fisher Scientific Inc.
TMO 544.81 (24.06.2022) 0.78 %
Tilray, Inc.
TLRY 3.61 (24.06.2022) 0.84 %
UnitedHealth Group, Inc.
UNH 495.64 (24.06.2022) -0.83 %
Veeva Systems Inc.
VEEV 207.04 (24.06.2022) 3.56 %
Zomedica Corp.
ZOM 0.2535 (24.06.2022) 5.23 %
Zynerba Pharmaceuticals, Inc.
ZYNE 1.25 (24.06.2022) 4.17 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.